Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: Described herein are methods of treating various disorders in patients in need thereof, comprising administering to the patient the compound of Formula (I) or a pharmaceutically acceptable salt thereof. Exemplary disorders that can be treated by the methods described herein include gynecologic carcinosarcomas, endometrial adenocarcinomas, mesotheliomas, ovarian cancers, pancreatic ductal adenocarcinomas, and lung cancers.

Abstract: Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: In an example, a media catcher may include a first frame member and a second frame member spaced away from the first frame member along a lateral direction, thereby defining a catcher width of the media catcher. Additionally, the media catcher may also include a device interface disposed at a top end of the first frame member or the second frame member. The device interface may attach the media catcher to an imaging device. The media catcher may further include a catch panel extending between the first frame member and the second frame member to catch and support media.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: The present disclosure relates to methods of treating gastrointestinal stromal tumors to a subject in need thereof, comprising administering to the subject a therapeutically effective amount of ripretinib or a pharmaceutically acceptable salt thereof.

Abstract: Described herein are methods of treating cancers and other tumors related to the decreased proliferation, the depletion, or the repolarization of tumor-associated macrophages (TAMs) and treatment of associated disorders, including tenosynovial giant cell tumor (TGCT) and diffuse-type tenosynovial giant cell tumor (DTGCT).

Abstract: A system comprises a hinge assembly and an anchor. The anchor has a base, a head, and a pin connecting the base and the head. The hinge assembly has an aperture and a notch narrower than the aperture extending from the aperture. The head fits through the aperture, and the notch is configured to receive the pin when the hinge assembly is translated toward the pin with the head through the aperture. The hinge assembly releasably clips to the pin to retain the hinge assembly in an engaged position when the notch receives the pin. The system may be a cargo system in a vehicle, with the lid serving as a vehicle load floor. A method of securing a lid to a cargo bin in a vehicle utilizes the system.

Abstract: A system comprises a hinge assembly and an anchor. The anchor has a base, a head, and a pin connecting the base and the head. The hinge assembly has an aperture and a notch narrower than the aperture extending from the aperture. The head fits through the aperture, and the notch is configured to receive the pin when the hinge assembly is translated toward the pin with the head through the aperture. The hinge assembly releasably clips to the pin to retain the hinge assembly in an engaged position when the notch receives the pin. The system may be a cargo system in a vehicle, with the lid serving as a vehicle load floor. A method of securing a lid to a cargo bin in a vehicle utilizes the system.

Abstract: A printer device comprising a mechanism adapted to generate an image on an image surface, the device comprising a sensor adapted to image a predetermined optical object located substantially on the image surface, the device being adapted to determine at least one dimension of the object's image and thereby determine the distance separating the mechanism and the image surface.

Abstract: Illumination utilizing a plurality of light sources is disclosed. In one embodiment, an illumination level is set to result in a desired contrast level. Calculations are made to derive electrical current values for each of the plurality of light sources which will illuminate a plurality of selected locations at the set illumination level.

Abstract: A multicolor-printer has at least a first and a second print station, first and second optical sensors and a surface recordings comparator. The first and second print stations are arranged to print images on a surface of a moving recording medium. The first and second optical sensors view, at the first and second print stations, an area of the recording medium surface to obtain at least one first surface recording, in a manner related to the first print station's image printing, and second surface recordings, respectively. A storage is arranged to store the first surface recording. The surface recordings comparator is arranged to test, during the recording medium movement, for correspondence of second surface recordings with the stored first surface recording.